易凯资本中国医疗健康产业白皮书2025 CEC Capital China Healthcare Industry White Paper 2025

1

CECCapitalChinaHealthcareIndustryWhitePaper2025

KeyPerspectives

2025.05

ThisarticlewasautomaticallytranslatedbyAI.

I.Overview

InourCECCapitalChinaHealthcareIndustryWhitePaper2024,releasedlastyear,we

estimatedthatasChinafullyemergedfromtheCOVID-19pandemic—whileaccountingfordomesticvolume-basedprocurement(VBP)policiesandongoinghealthcareanti-corruptionefforts—thecountry’shealthcareindustryreachedanestimatedmarketsizeof

approximatelyRMB13.3trillion(aroundUSD1.8trillion)in2023.Thisincludedroughly

RMB3trillioninpharmaceutical-relatedmarkets,RMB1.2trillionacrossmedicaldevices

anddiagnostics,andapproximatelyRMB9.1trillionencompassinghealthcareservices,

digitalhealth,andwellnesssectors.Afteradjustingforoverlappingsegments,weprojected

2

thetotalmarketsizeofChina’shealthcareindustryin2023tobebetweenRMB10.5trillionandRMB11.0trillion(USD1.4–1.5trillion).

In2024,withChina’seconomygenerallystabilizingandthehealthcareindustrycontinuingtoexpandinscope,weestimatethemarketsizeofChina’shealthcaresectorasfollows:

thepharmaceutical-relatedmarketremainssteadyatapproximatelyRMB3trillion,similarto2023;themedicaldevicesanddiagnosticssegmentisprojectedtogrowmodestly,

reachingaroundRMB1.4trillion.DrivenbyChina’srapidlyagingpopulationandthe

wideningindustryboundariesenabledbyemergingtechnologies—suchasartificial

intelligence,robotics,andbiomanufacturing—weforecastthecombinedmarketsizeof

healthcareservices,digitalhealth,andbroaderhealth-relatedsectorstoreachRMB10

trillion.Afteradjustingforoverlappingcomponents,weestimatethetotalsizeofChina’s

healthcareindustryin2024torangebetweenRMB11.5trillionandRMB12.0trillion(USD1.5–1.6trillion),reflectingayear-on-yeargrowthrateof9%to10%.

Rapidpopulationagingisaglobalphenomenon,andChinaisexperiencingoneofthemostrapidandlarge-scaledemographicshiftsinhistory—atrendexpectedtoaccelerate

significantlyoverthenexttwodecades.ThisdemographictransitionpresentsbothsystemicchallengestoChina’ssocioeconomicfabricandtransformativeopportunitiesforindustrial

growth.TheagingpopulationisplacingunprecedentedstrainonChina’shealthcare

infrastructure,whilesimultaneouslydrivingtheriseofasubstantialelderlycareeconomy

withsignificantgrowthpotential.AccordingtoprojectionsfromtheChinaResearchCenteronAging,theelderlycareeconomyisexpectedtoreachRMB30trillionby2035,

accountingforroughly10%ofGDP,withhealth-relatedtechnologicalinnovationand

evolvingconsumerdemandemergingaskeyenginesofeconomicgrowth.Weanticipate

thattechnologiessuchasartificialintelligence,embodiedrobotics,andbrain-computer

interfaces(BCI)—onceconfinedtotherealmofsciencefiction—willrapidlyevolveinto

practicalsolutionsforeldercare,offeringinnovativeapproachesforChinesesocietytomeetthechallengesofanagingpopulation.

Thereformandopening-upinitiativelaunchedinthelate1970stransformedChinaintoa

globallycompetitivemanufacturingpowerhouseoverthepastfourdecades.Today,Chinaisevolvingbeyonditsroleasamanufacturingleadertobecomeaglobalhubfor

technologicalinnovation,productR&D,andtheexportofintellectualproperty(IP).Chineseinnovationisgaininginternationalprominenceacrosssectors—fromnewenergyvehiclesrepresentedbyBYD,andsemiconductormanufacturingledbyHuawei,toartificial

intelligenceexemplifiedbyDeepSeek,andculturalIPshowcasedbyBlackMyth:WukongandNezha.

China’sgrowinginnovationcapabilities,R&Dstrength,andexpandingIPexportsare

playinganincreasinglyimportantroleinadvancingglobalhealthcare.China'shealthcare

innovationisbeingpropelledbyincreasingdemandandrapidaccelerationoftechnologicaldevelopment.Thisdynamicnotonlyhelpsaddressglobaldisparitiesinmedicalresource

3

allocationbutalsoacceleratesChina’stransformationfromthe“world’sfactory”intoa“globallaboratory”andan“innovationepicenter.”

In1994,ProfessorWilliamKissickofYaleUniversityintroducedtheIronTriangleof

Healthcare,arenownedframeworkthatdescribestheinherenttensionwithintraditional

healthcaresystems:highquality,lowcost,andbroadaccessibilityareuniversallydesired,yetonlytwooftheseobjectivescantypicallybeachievedsimultaneously.Throughout

humanhistory,qualityhealthcarehasneverbeenanequal-accessresource—itremainsascarceasset,andattimes,aprivilegethatwealthalonecannotfullysecure.

OneofthemostpressingchallengesofChina’srapidlyagingsocietyispreciselythis

scarcityofmedicalresources.Incitieswithdenseelderlypopulations,healthcaredemandissurging,whilemedicalexpertiseandresourcesremaindisproportionatelyconcentratedinfirst-tierurbancenters,resultinginseveredistributionimbalances.

Today,theacceleratingprogressofartificialintelligence(AI)androbotics—particularly

embodiedrobotics—offersapathwaytopartiallyalleviatetheconstraintsoftheIron

Triangle.Thesetechnologiesholdvastpotentialacrossnumeroushealthcareapplications,includingAI-assisteddiagnosis,medicalimaginginterpretation,surgicalplanningand

execution,chronicdiseasemanagement,healthmonitoring,newdrugdevelopment,postoperativerehabilitation,andelderlycare.

WhileAIandroboticswilllikelyneverfullyreplacetheexpertiseofskilledphysiciansand

specialists,technologicaladvancementsaresteadilypropellingChinesesocietytowardthelong-termgoalofhealthcareequity.Theroadaheadremainschallenging—butthefirst

lightofthatfutureisalreadyvisible.

Bio-manufacturingandsyntheticbiology,muchlikeartificialintelligence,exhibits

foundationalinfrastructuralcharacteristicsandisemergingasacoredriverinthe

transformationoftraditionalindustries.Overthenext5to10years,itisexpectedtofundamentallyreshapeglobalindustrialecosystemsacrossbiopharmaceuticals,foodproduction,andagriculture.

Projectionsindicatethatthesector’smarketsizewillexpandfromRMB417.6billionin

2023toRMB476.2billionin2024,representingyear-on-yeargrowthofover15%.By2030,China’sbio-manufacturingmarketisprojectedtoreachapproximatelyRMB1.8trillion,

whiletheglobalmarketisforecasttosurpassUSD1.1trillion(aroundRMB8trillion),withChinaaccountingfornearly23%ofglobalcapacity.

OuranalysissuggeststhatChina’sgrowingtechnologicalleadershipandstrongindustrial

baseareenablingitstransitionfromparticipantandcontributortocatalystandgloballeaderinbio-manufacturing.Thecountryiswell-positionedtobecomeacentralhubinglobalbio-

4

production,extendingitslong-standingindustrialmanufacturingstrengthsintothisstrategicallycriticalsector.

In2024,China’shealthcareindustryrecordedapproximately148M&AtransactionstotalingRMB75billion,markingaclearreboundfromthedownturnin2023.Thetotaldealvalue

approachedthe2021peak,making2024thesecond-highesttransactionyearsince2019.ThenormalizationofM&AactivityinChina’shealthcaresectorrepresentsanimportant

milestoneinbothindustrydevelopmentandcapitalmarketmaturation,usheringinaneweraofconsolidation.

A-sharelistedcompaniesremainthedominantforceinChina’sM&Amarket,leveraging

capitalstrengthandindustrialsynergiestoleadindeal-making.Thestrategicrationale

behindM&Ahasevolvedfromafocusonmarketcapitalizationmanagementtowarddeeperverticalintegration.Theongoingcapitalinvestmentwinterhasforcedmorerational

valuations,bringinghigh-qualityassetstomarketatmoreattractivepricepoints.Theadoptionofinnovativedealstructureshasfurtherenhancedtransactionviability,

significantlyacceleratingdealmomentumonboththebuyandsellsides.

Webelievethatinthisenvironment,aclearlyarticulatedM&Astrategy,strongexecutioncapabilities,anddisciplinedpost-mergerintegrationarecriticalcompetenciesthatwill

enableleadingplayerstonavigatemarketcyclesandreshapethecompetitivelandscape.

II.TheMostSignificantInvestmentThemesinChina'sHealthcareIndustryToday

1.Populationagingisaglobaltrend,andisparticularlyacuteinChina.Thecountryisundergoingtheworld’slargestandfastestagingprocess—ademographicshiftthatwillintensifymarkedlyoverthenexttwodecades.Thistransformationpresentsbothsignificantchallengesandnewopportunitiesforsocietalevolution.

1)China’sagingpopulationisexpandingatanexceptionallyrapidratebothinscaleandpace,placingsustainedpressureonsocialsecurityandelderlycaresystems.

China’selderlypopulationhasreachedanunprecedentedscale.Asof2024,thereare310millionpeopleaged60andabove(22%ofthetotalpopulation),including220millionaged65andolder(15.6%),signifyingthecountry’stransitionintomoderateaging.Overthenextdecade(2025–2035),the60+populationisprojectedtogrowbymorethan10million

annually,surpassing400millionby2035andaccountingforover30%ofthetotal

population—movingsocietyintoaneraofsevereaging.Byaround2050,China’selderly

5

populationisexpectedtopeakat487million,representingone-quarteroftheworld’selderlypopulation,withanagingrateof34%—twicetheglobalaverage.

Thepaceofthisdemographicshiftisunprecedented.China’sagingrateisprojectedtorisefrom10%in2000toover20%by2025andsurpass30%by2035—completingthe

transitionfrommildtosevereaginginjust35years,farfasterthaninWesterneconomies.Atthesametime,theworking-agepopulation(ages20–64)isprojectedtoshrinkby47

millionby2035andby124millionby2050,exacerbatingstructuralimbalancesbetweenlaborsupplyandpensiondemand.

Severeagingbringsmultiplesystemicchallenges:theelderlydependencyratiocontinuestorise,pensionfundinggapsarewidening,anddemandforhealthcareandlong-termcareissurging.Forexample,thepotentialworkforcerequiredfordisabledelderlycarecould

reach74millionby2050—representing11%oftheworking-agepopulation.Starkurban-ruraldisparitiespersist:ruralregionsareagingfasterthanurbanareasbutlackadequateelderlycareinfrastructure.

Atthesametime,decliningbirthratesanddemographicimbalancesremainunresolved.In2024,Chinarecorded9.54millionbirths—anincreaseof520,000from9.02millionin

2023—endingaseven-yearconsecutivedeclinesince2016.However,thebirthrate

remainslowatjust6.77‰,andoverallpopulationgrowthremainsnegative.Thedual

challengesofagingandlowfertilityratescontinuetostrainfamilysupportstructuresandintensifyintergenerationalpressures.

2)PopulationagingisplacingunprecedentedpressureonChina’shealthcareand

medicalservicesindustry,whilesimultaneouslycreatingsignificantnew

opportunities.Bothsupply-sideplayersandpayerstakeholdersarerapidlyadaptingtothisevolvinglandscape.Theelderlycareeconomyisdrivingsubstantialmarket

expansionandhasbecomeakeyfocusofbroadersocioeconomicdevelopment.

lAgingpopulationspresenttheclearestgrowthopportunitiesinspecializedhealthcaresegments—particularlyinmedicalnutrition,chronicdiseasemanagement,

rehabilitation,andlong-termcarefordisabledpatients.

Demandforfoodforspecialmedicalpurposes(FSMP)isgrowingexponentially,fueledbydemographicshiftsandchangingdiseasepatterns.Withacceleratedaging,Chinaisfacingaworseningprevalenceofchronicdiseases.Datashowsthatamongresidentsaged40

andabove,thecombinedmorbidityrateforcardiovasculardiseases,cancer,anddiabeteshasreached34.3%.Moreover,80%ofpatientswithchronicdiseasessufferfromnutritionalimbalances.Amonghospitalizedelderlypatients,theincidenceofmalnutritionreaches

65%,with42%experiencingmorethan5%bodyweightlossduringhospitalization—significantlyincreasinginfectionriskandprolongingrecoverytimes.

6

FSMPprovidestargetednutritionalinterventionstoaddressthesechallenges.Clinical

evidenceshowsthatelderlypatientsreceivingstandardizedFSMPprotocolsexperience

35%slowermuscleloss,a28%reductionininfectionrates,andanaveragehospitalstay

shortenedby12days.Indiabetes-specificFSMP,formulationsincorporatingresistant

dextrinanddietaryfiberreducepostprandialglucosefluctuationsby40%,withthissegmentprojectedtoexceedRMB7.5billioninmarketsizein2024.InoncologyFSMP,formulationsenrichedwithω-3fattyacidsandargininehaveraisedweightmaintenanceratesto78%—a26-percentage-pointimprovementoverconventionalnutritionalsupport.

China’sFSMP(FoodforSpecialMedicalPurposes)marketisexpandingrapidly,withacompoundannualgrowthrate(CAGR)of30%.ThemarketisprojectedtoreachRMB

23.42billionin2024andexceedRMB80billionby2030,establishingFSMPasatrillion-

yuangrowthpillarwithintheelderlyeconomy.Thesectorisevolvingfromamedicaladjunctintoacorecomponentofroutinehealthmanagement.

Regulatoryauthoritiescontinuetointroducefavorablepoliciestosupportindustry

development.TherevisedAdministrativeMeasuresforRegistrationofFoodsforSpecial

MedicalPurposes(2023)shortenedthestandardapprovalcycleto18months,withpriorityreviewproductsnoweligibleforacceleratedapprovalwithinjust30days.In2024,196

domesticallyproducedFSMPproductswereapprovedacrossthreekeycategories:

completenutrition,disease-specificcompletenutrition,andnon-completenutrition.

Simultaneously,severalcities—ledbyWuxi—havebegunincorporatingFSMPintomedicalinsurancecoverage,drivingfasteradoptionandindustrypenetration.

Thissectorisalsoattractingincreasingattentionfrominvestors,withseveralsignificant

transactionsrecentlyemerging.Drivenbystrongsupplyanddemanddynamics,we

recommendfocusingonenterprisespursuingbreakthroughinnovationsinthreekeyareas:

lOvercomingtechnicalbarrierstodemonstrateR&DstrengthandenabledomesticsubstitutionofspecializedimportedFSMPproducts.

lLeveragingsyntheticbiologyapplicationstoachievetransformativecostadvantages.

lIntegratingAItechnologiestodeveloppersonalized,AI-drivennutritionsolutionsandestablishdifferentiatedmarketpositioning.

Atthesametime,China’schronicdiseasemanagementindustryisundergoingaparadigmshift—movingfrompassivetreatmenttowardproactivecare.Chinacurrentlyhasover460millionchronicdiseasepatients,withaprevalencerateof62.3%amongthoseaged65andolder.Chronicconditionssuchascardiovasculardiseasesanddiabetesaccountforover

70%oftotalhealthcareexpenditures,fuelingthegrowthofahealthmanagementmarketnowvaluedatseveralhundredbillionyuan.

7

China’schronicdiseasehealthmanagementindustryhassteadilyevolved,withits

ecosystemnowspanningfivekeyareas:pharmaceuticalcompanies,hospitals,

pharmacies,homecare,andinsurance.Marketplayersarepursuingdiverseentry

strategiestailoredtotheirrespectivecapabilitiesandresourceadvantages.Forexample,e-commerceplatformssuchasAliHealthandJDHealthleveragetheirstrongdistribution

channelstoexpandintohealthcareservices.Insurance-backedplayerslikePingAnGoodDoctordrawontheirlargepolicyholderbases,whilecompaniessuchasArkHealthrelyonphysiciannetworkstoenterthetelemedicineandmedicationprocurementspace.These

differentiatedapproachesaimtodelivercontinuous,integratedcare—bothwithinand

beyondhospitalsettings—toChina’svastchronicdiseasepatientpopulation.Buildingalargepatientbaseandcreatingclosed-loopbusinessmodelsacrossservicetouchpointsremainkeycompetitiveadvantages.

WebelievetherapidadvancementofAIfoundationmodelswillfurtherenergizethissector,creatingnewopportunitiesininternet-basedhealthmanagementandenablingmore

proactivechronicdiseaseinterventions.Forexample:

lAI-powereddynamicriskpredictionsystemscananalyzelarge-scalepatientdatasetstoforecastacutecomplicationrisksuptosixmonthsinadvance,helpingreducetheincidenceofchronicdiseasecomplications.

lPersonalizedbehaviormodificationengines,utilizingreinforcementlearning

algorithms,cancontinuouslyadjustinterventionstrategies.Byanalyzingpatient

dietaryandexercisedata,thesesystemsgeneratetailoredplanstopromotelong-termlifestyleoptimizationforchronicdiseasepatients.

MedicalAIfoundationmodelsarepropellingthechronicdiseasemanagementindustryintoaneweraofpredictive,preventive,personalized,andparticipatory(4P)medicine.

Companiesthatcombinestrengthsindata,algorithms,andecosystemintegrationwillbebestpositionedtoleadthistransformation.

TherehabilitationhealthcaresectorhasalsoemergedasakeygrowthareawithinChina’sprecisionhealthcaretransformation,withitsinelasticdemandcontinuingtorise.The

rehabilitationmarkethassurpassedRMB700billion,withgeriatricrehabilitationaccountingfor58%ofthistotal.Statisticsshowthat60%ofindividualsaged60andaboverequire

rehabilitationservices(e.g.,post-stroke,post-fracturesurgery,cognitiveimpairment),withpotentialservicevolumeexceeding145millionpatientsin2024.

Keyclinicalscenariosinclude:

lNeurologicalRehabilitation:Strokepatientshaveacriticaltreatmentwindowwithin

3–6monthspost-onset,yetonly38%receivedsystematicrehabilitationin2024.

8

lPost-SurgicalRehabilitation:Demandamongkneereplacementpatientsishighlyconcentratedwithinthefirstthreemonthspost-operation,whilepublichospital

rehabilitationbedshaveanaveragewaitingperiodof4.2weeks.

lGeriatricSyndromeManagement:72%offunctionallyimpairedseniorsrequirecombinedphysicaltherapyandcognitivetraining,yetcurrentservicecoverage

remainsbelow20%.

China’srehabilitationmedicalinstitutionsarepredominantlyprivatelyoperated,yetthesectorfacesseveresupplyshortages.Asof2024,therewereonly823rehabilitation

hospitalsnationwide(152publicand671private),translatingtojust6.1facilitiesper10millionpeople—wellbelowtheOECDaverageof15.3.Rehabilitationbedsaccountforonly1.8%oftotalhospitalbeds(327,000bedsin2024),comparedto12%intheUnitedStates.

Governmentpolicyexplicitlyencouragesthedevelopmentofchain-basedprivate

rehabilitationhospitals.The14thFive-YearPlanforDigitalEconomyDevelopmentcallsfor"supportingnon-governmentalentitiesinestablishingchain-basedandgroup-based

rehabilitationmedicalinstitutions,andpromotingtheextensionofrehabilitationservicestocommunitiesandhouseholds."Inparallel,theOpinionsonPromotingtheSustainable,

HealthyandStandardizedDevelopmentofNon-PublicMedicalInstitutionsallowsprivaterehabilitationhospitalstoexceedregionalbedquotas,withchainoperatorseligiblefora"one-license,multiple-location"registrationsystem.Arangeofconstructionsubsidies,taxincentives,andothersupportivemeasuresarealsoinplacetoencourageprivatesectorparticipation.

Againstthisbackdrop,wemaintainapositiveoutlookforthedevelopmentofprivate

rehabilitationmedicalinstitutionsoverthenext3–5years,withparticularattentionto

operatorsdemonstratingexperiencedoperationalandmanagementcapabilities.Atthe

sametime,demandforintelligentrehabilitationhardwareandassistivedevicescontinuestoexpand.Theintegrationofemergingtechnologies—includingVR/ARsystems,

exoskeletonroboticplatforms,and3Dprinting—withAI-drivenalgorithmsispropellingtechnologicaladvancementsintherehabilitationequipmentsector.

Disabilitycareserviceshavebecomeacriticalfrontierforprofessionalizationand

standardization.Chinacurrentlyhas45millionelderlyindividualswithdisabilities,ofwhom32%areseverelydisabled.Theaveragecaredurationexceeds7.3years,withannual

nursingcostssurpassingRMB50,000—fuelingexplosivedemandasthepopulation

continuestoagerapidly.However,thedisabilitycaresectorfacesapronouncedsupply-

demandgap.Internationalbenchmarksrecommendanursingbedratioof1:3(onebedperthreedisabledelderly),whichimpliesthatChinashouldhave8–10millionprofessional

nursingbedswhenaccountingforadditionaldemandfromdementia,post-operative

9

rehabilitation,andrelatedconditions.Yet,asof2024,China’selderlycareinstitutions

providedonlyabout3.2millionnursingbeds—leavingashortfallofover6millionbeds.

Againstthisbackdrop,thegovernmentisactivelypromotingprivatesectorinvestmentin

integratedeldercareandmedicalservices.TheNationalHealthCommissionhasadoptedamulti-prongedapproachtoenhanceadministrativeefficiency,includingstreamlining

approvalprocessesthroughrecord-filingmanagementandconsolidatingestablishment

approvalswithoperationalregistrations.Intermsoffacilitydevelopment,theCommission

hasremovedregionalquotarestrictionsforprivatelyoperatedeldercaremedicalinstitutionsandacceleratedtheinclusionofqualifiedmedicalfacilitieswithinretirementcommunities

intothedesignatedmedicalinsurancenetwork.Localgovernmentsarealsoencouragedtoestablishindustrialinvestmentfundstofurthersupportsectorgrowth.

Theacceleratingagingtrendistransforminglong-termcareinsuranceanddisabilitycare

intoatrillion-yuanmarket.Structuralinefficienciesinthepublicsystem—spanningservicequality,technologicaladvancement,andpaymentflexibility—arecreatingsignificant

opportunitiesforprivateoperators.Leadingenterpriseswithstrongchainoperation

capabilities,intelligentserviceplatforms,andintegratedvaluechaincompetenciesareprojectedtocapturemorethan70%ofmarketshareby2030.

lChina’ssocialhealthinsurance,theprimarypayer,isundermountingpressureamiddemographicaging,spurringtheriseofdiversifiedalternativepayment

mechanismssuchasprivatepensioninsuranceandcommercialpensioninsurancetostrengthentheoverallpaymentsystem.

China’shealthcareinsurancefundisfacinggrowingchallengesinmaintainingfiscal

sustainabilityandhasnowenteredacriticalinflectionperiodmarkedby“declining

contributionsandrisingexpenditures.”Whilethenationalemployeemedicalinsurancefundremainsinsurplus(RMB416.4billionasof2024),theresidentmedicalinsurancesystemisunderincreasingstrain.Forexample,in2024Tianjin’surban-ruralresidentmedical

insurancefundpostedcontributionsofRMB5.88billionversusexpendituresofRMB7.24billion,resultinginadeficitofRMB1.36billion.Similarly,Beijing’smedicalinsurance

programrecordedanannualfundinggapofRMB526million.

Theunderlyingcauseofthisimbalanceisdemographicinnature:individualsaged65andoldernowaccountfor13.5%ofthepopulation,withpercapitamedicalexpenditures3-5

timeshigherthanthoseofyoungeragegroups.UnderChina’spay-as-you-gosystem,a

shrinkingcontributorbasecombinedwithagrowingpoolofelderlybeneficiariesiscreatingseverefiscalchallengesforthehealthinsurancesystem.

ThenationalrolloutofpersonalpensioninsurancewillbecompletedbyDecember2024,

markingtheformalestablishmentofathirdpillarinChina’spensionsystemtocomplementbasicmedicalinsuranceandenterpriseannuities.However,currentresidentcontribution

patternsindicatelimitedparticipationenthusiasm.Bytheendof2024,approximately70

10

millionpersonalpensionaccountshadbeenopened,representing42%ofurbanemployeebasicpensioninsuranceparticipants,withactualcontributorsaccountingforlessthan30%ofaccountholders.Twoprimaryfactorshavecontributedtothisphenomenon:first,currenttaxincentivesexcludeindividualswithannualincomesbelowRMB96,000,thereby

dampeningparticipationamongmiddle-tolow-incomegroups;second,asclosed-endinvestmentaccounts,theseproductslackcompetitiveyieldadvantagescomparedtoalternativewealthmanagementinstruments,fosteringwait-and-seeattitudesamongpotentialcontributors.Potentialpolicyrelaxationsregardingtaxincentivesandearly

withdrawalmechanismsareanticipatedtoenhancetheproduct’soverallappeal.

Concurrently,thecommercialpensioninsurancemarketcontinuestoexpand,supportedbyactivegovernmentpromotionandmultiplepolicyincentives.RegionssuchasShanghai

andShandonghavesuccessivelyimplemented"medicalinsurance+commercial

insurance"one-stopsettlementsystems,coveringover1,000publicandprivatehospitals

whilereducingclaimsprocessingcyclestoundertwohours.Thelong-termcareinsurancepilotprogramisaccelerating,withmandatorycoveragetargetssetfor50%ofprefecture-

levelcitiesnationwidebytheendof2025.Thisinitiativeestablishesatripartitefunding

mechanisminvolvinggovernment,enterprises,andindividuals,whileenablinginsurersto

developsupplementalproductscoveringnon-policynursingdurationsandpremiumcare

institutions.Atthenationalhealthcaresecurityadministrationlevel,effortsareunderwaytoexpeditetheopeningofmedicalinsurancedatatocommercialinsurers.Commercial

insurance,asasupplementtopublichealthcare,isprogressivelytransitioningfromsingularfinancialsupplementationtocomprehensivelifecyclehealthmanagement.

By2035,China’selderlycareeconomyisprojectedtoreachRMB30trillion,

accountingforapproximately10%ofGDP,withhealth-relatedconsumptionpoisedtobecomeasignificantmarketgrowthdriver.

Theperiodfrom2025to2035representsacriticaltransitionwindow,asChina’saging

populationmovesfrommoderatetoseverelevels.Inthecomingdecade,retireeswill

primarilycompriseyoungerseniorsaged60–74,whogenerallyenjoybetterhealthand

possesssubstantialaccumulatedwealth.Thisdemographicwillserveasthecoredriverofthe"eldereconomybenefit."ProjectionsindicatethatChina’selderlycareeconomywill

expandfromapproximatelyRMB9–10trilliontodaytoRMB30trillionby2035,

representingacompoundannualgrowthrateof12%–15%.Thisgrowthwillbefueledbypolicytailwinds,technologicalinnovation,andincreasingconsumption—thoughitwill

requirecarefulmanagementofregionaldisparitiesandvaryingpaymen